Rebecca Velez Frey
Director/Board Member at Siduma Therapeutics, Inc.
Network origin in Rebecca Velez Frey first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 89 | |
Elm Street Advisors LLC
 Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.
10
| Private Company | Investment Managers | 10 |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Halda Therapeutics LLC
 Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT.
4
| Holding Company | Medical/Nursing Services | 4 |
Siduma Therapeutics, Inc.
 Siduma Therapeutics, Inc. BiotechnologyHealth Technology Siduma Therapeutics, Inc. develops medicines that utilize the body's innate biology.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rebecca Velez Frey via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Director of Finance/CFO | |
| VERISIGN. INC. | Internet Software/Services | Human Resources Officer Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Human Resources Officer Sales & Marketing | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
AxioMx, Inc.
 AxioMx, Inc. Pharmaceuticals: MajorHealth Technology AxioMx, Inc. develops and produces recombinant antibody technologies. Its service offerings include antigen & project design, recombinant antibody development, antibody optimization, and antibody production. The company was founded by Christopher K. McLeod and Michael P. Weiner in 2012 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| BAXALTA INC | Biotechnology | Human Resources Officer Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Public Communications Contact Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Compliance Officer | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Indiana University | College/University | Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
| University of Massachusetts | College/University | Doctorate Degree Masters Business Admin | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Comptroller/Controller/Auditor | |
| ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Human Resources Officer Director of Finance/CFO | |
| ALLOVIR, INC. | Biotechnology | President Chairman General Counsel Director/Board Member Chief Tech/Sci/R&D Officer | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Stradefy Biosciences, Inc.
 Stradefy Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Stradefy Biosciences, Inc. provides commercial physical and biological research. The company is based in New Haven, CT. The CEO of the company is Brian R. Dixon. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| CHEMOMAB THERAPEUTICS LTD. | Biotechnology | Chairman Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member Founder Director/Board Member | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistics
International
| United States | 46 |
| France | 2 |
| Netherlands | 2 |
| Switzerland | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Technology Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 429 |
| Corporate Officer/Principal | 248 |
| Independent Dir/Board Member | 145 |
| Undergraduate Degree | 83 |
| Chief Executive Officer | 75 |
Most connected contacts
| Insiders | |
|---|---|
| Amy Schulman | 45 |
| Stephen P. Squinto | 40 |
| Liam Ratcliffe | 32 |
| Felix Baker | 28 |
| Rockford Norby | 28 |
| Timothy Shannon | 28 |
| Martin MacKay | 28 |
| Max E. Link | 28 |
| William Keller | 26 |
| Christopher Coughlin | 23 |
| M. Burns | 23 |
| Edward Mascioli | 22 |
| Paul Friedman | 21 |
| Dave Anderson | 21 |
| Jimmy C. Lu | 19 |
- Stock Market
- Insiders
- Rebecca Velez Frey
- Company connections
